IGLV3-21(R110) identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics

B-cell receptor (BCR) signaling is crucial for chronic lymphocytic leukemia (CLL) biology. IGLV3-21–expressing B cells may acquire a single point mutation (R110) that triggers autonomous BCR signaling, conferring aggressive behavior. Epigenetic studies have defined 3 CLL subtypes based on methylatio...

詳細記述

保存先:
書誌詳細
出版年:Blood
主要な著者: Nadeu, Ferran, Royo, Romina, Clot, Guillem, Duran-Ferrer, Martí, Navarro, Alba, Martín, Silvia, Lu, Junyan, Zenz, Thorsten, Baumann, Tycho, Jares, Pedro, Puente, Xose S., Martín-Subero, José I., Delgado, Julio, Campo, Elías
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Hematology 2021
主題:
Lymphoid Neoplasia
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8191863/
https://ncbi.nlm.nih.gov/pubmed/33211804
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2020008311
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料